Katherine F Sweeny1, Tom K Lin2,3, Jaimie D Nathan4, Lee A Denson2,3, Sohail Z Husain5, Lindsey Hornung6, Tyler Thompson2, Maisam Abu-El-Haija2,3. 1. Department of Pediatrics. 2. Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center. 3. Department of Pediatrics, College of Medicine, University of Cincinnati. 4. Department of General and Thoracic Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, OH. 5. Department of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Pittsburgh, Pittsburgh, PA. 6. Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Abstract
OBJECTIVE: Research is lacking on the natural history of acute pancreatitis (AP) progression to acute recurrent pancreatitis (ARP). The aim of this project was to study the progression from AP to ARP among pediatric patients with pancreatitis to better understand the presentation and natural history of pancreatitis. METHODS: Patients presenting with AP were included in a prospective database in Research Electronic Data Capture. We enrolled 115 patients with AP from March 2013 to November 2016. Physicians completed surveys regarding clinical data for patients with first attack of AP. Patients were followed prospectively, with data on progression entered when patients presented with ARP. RESULTS: The most common etiologies for the first attack of AP were idiopathic (31%), toxic/drug-related (23%), and biliary/gallstone (18%). Twenty of the 115 patients (17%) developed ARP during the follow-up period. Seventy percent (14/20) of patients with ARP progressed from AP to ARP within 5 months from first diagnosis. A comparison of patients who rapidly progressed to ARP within 3 months (n = 12) to those followed for >3 months without progression in 3 months (n = 97) revealed associations with a higher weight percentile for age (P = 0.045), male sex (P = 0.03), and presence of pancreatic necrosis during first AP attack (P = 0.004). Progression to ARP significantly differed by etiology group with genetics having the highest risk for ARP progression over time and patients with gallstone/biliary, viral/systemic, and obstructive (nongallstone) having the lowest risk for ARP progression over time (P = 0.02). CONCLUSIONS: Most patients who progressed from AP to ARP progressed within 5 months. The presence of a higher weight percentile for age, male sex, and pancreatic necrosis during the first AP attack are associated with rapid progression to ARP.
OBJECTIVE: Research is lacking on the natural history of acute pancreatitis (AP) progression to acute recurrent pancreatitis (ARP). The aim of this project was to study the progression from AP to ARP among pediatric patients with pancreatitis to better understand the presentation and natural history of pancreatitis. METHODS:Patients presenting with AP were included in a prospective database in Research Electronic Data Capture. We enrolled 115 patients with AP from March 2013 to November 2016. Physicians completed surveys regarding clinical data for patients with first attack of AP. Patients were followed prospectively, with data on progression entered when patients presented with ARP. RESULTS: The most common etiologies for the first attack of AP were idiopathic (31%), toxic/drug-related (23%), and biliary/gallstone (18%). Twenty of the 115 patients (17%) developed ARP during the follow-up period. Seventy percent (14/20) of patients with ARP progressed from AP to ARP within 5 months from first diagnosis. A comparison of patients who rapidly progressed to ARP within 3 months (n = 12) to those followed for >3 months without progression in 3 months (n = 97) revealed associations with a higher weight percentile for age (P = 0.045), male sex (P = 0.03), and presence of pancreatic necrosis during first AP attack (P = 0.004). Progression to ARP significantly differed by etiology group with genetics having the highest risk for ARP progression over time and patients with gallstone/biliary, viral/systemic, and obstructive (nongallstone) having the lowest risk for ARP progression over time (P = 0.02). CONCLUSIONS: Most patients who progressed from AP to ARP progressed within 5 months. The presence of a higher weight percentile for age, male sex, and pancreatic necrosis during the first AP attack are associated with rapid progression to ARP.
Authors: Veronique D Morinville; Sohail Z Husain; Harrison Bai; Bradley Barth; Rabea Alhosh; Peter R Durie; Steven D Freedman; Ryan Himes; Mark E Lowe; John Pohl; Steven Werlin; Michael Wilschanski; Aliye Uc Journal: J Pediatr Gastroenterol Nutr Date: 2012-09 Impact factor: 2.839
Authors: Michael H Ma; Harrison X Bai; Alexander J Park; Sahibzada U Latif; Pramod K Mistry; Dinesh Pashankar; Veronika S Northrup; Vineet Bhandari; Sohail Z Husain Journal: J Pediatr Gastroenterol Nutr Date: 2012-05 Impact factor: 2.839
Authors: Gregory A Coté; Dhiraj Yadav; Adam Slivka; Robert H Hawes; Michelle A Anderson; Frank R Burton; Randall E Brand; Peter A Banks; Michele D Lewis; James A Disario; Timothy B Gardner; Andres Gelrud; Stephen T Amann; John Baillie; Mary E Money; Michael O'Connell; David C Whitcomb; Stuart Sherman Journal: Clin Gastroenterol Hepatol Date: 2010-10-26 Impact factor: 11.382
Authors: Chaitanya Pant; Thomas J Sferra; Brian R Lee; Jose T Cocjin; Mojtaba Olyaee Journal: J Pediatr Gastroenterol Nutr Date: 2016-03 Impact factor: 2.839
Authors: Jonas Rosendahl; Heiko Witt; Richárd Szmola; Eesh Bhatia; Béla Ozsvári; Olfert Landt; Hans-Ulrich Schulz; Thomas M Gress; Roland Pfützer; Matthias Löhr; Peter Kovacs; Matthias Blüher; Michael Stumvoll; Gourdas Choudhuri; Péter Hegyi; René H M te Morsche; Joost P H Drenth; Kaspar Truninger; Milan Macek; Gero Puhl; Ulrike Witt; Hartmut Schmidt; Carsten Büning; Johann Ockenga; Andreas Kage; David Alexander Groneberg; Renate Nickel; Thomas Berg; Bertram Wiedenmann; Hans Bödeker; Volker Keim; Joachim Mössner; Niels Teich; Miklós Sahin-Tóth Journal: Nat Genet Date: 2007-12-02 Impact factor: 38.330
Authors: Sarah H Orkin; Andrew T Trout; Lin Fei; Tom K Lin; Jaimie D Nathan; Tyler Thompson; David S Vitale; Maisam Abu-El-Haija Journal: J Pediatr Date: 2019-08-06 Impact factor: 4.406
Authors: Maisam Abu-El-Haija; Lindsey Hornung; Tom K Lin; Jaimie D Nathan; Tyler Thompson; David S Vitale; Alexander Nasr; Sohail Z Husain; Lee Denson Journal: Pancreatology Date: 2020-07-24 Impact factor: 3.996
Authors: David S Vitale; Patrick Lahni; Lindsey Hornung; Tyler Thompson; Peter R Farrell; Tom K Lin; Jaimie D Nathan; Hector R Wong; Maisam Abu-El-Haija Journal: PLoS One Date: 2022-02-14 Impact factor: 3.240